Litcius/Paper detail

Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study

Camille Lanaret, Dany Anglicheau, Vincent Audard, M. Büchler, Sophie Caillard, Lionel Couzi, Paolo Malvezzi, Laurent Mesnard, Dominique Bertrand, Franck Martinez, Vincent Pernin, Didier Ducloux, Coralie Poulain, Antoine Thierry, Arnaud Del Bello, Jean P. Rerolle, Clarisse Grèze, Charlotte Uro-Coste, Julien Aniort, Céline Lambert, Nicolas Bouvier, Betoul Schvartz, Nicolas Maillard, Johnny Sayegh, Julie Oniszczuk, Marie-Pascale Morin, Christophe Legendre, Nassim Kamar, Anne E. Heng, Cyril Garrouste

2021American Journal of Transplantation26 citationsDOI

Topics & Concepts

MedicineRituximabDiscontinuationFocal segmental glomerulosclerosisInternal medicineHypogammaglobulinemiaCalcineurinTransplantationGastroenterologyPlasmapheresisKidney transplantationImmunosuppressionSurgeryKidneyImmunologyGlomerulonephritisAntibodyLymphomaRenal Diseases and GlomerulopathiesVasculitis and related conditionsAmyloidosis: Diagnosis, Treatment, Outcomes
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study | Litcius